Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-21-023086

Chief Business Officer acquired 4,330 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Beaurang Pierre · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-03-25 Exercise or conversion : show line 1 in the form +4,330 $0.84 $3,637 4,330 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-25 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −4,330 $0.84 2026-01-27 4,330 2,396 D
Loading xslF345X03/doc4.xml…